Huang et al. [198] suggested that recombinant ACE2-Fc proteins not only worked as antibodies to block viral invasion and generate long-term immunity, but they could also act as a complement to decrease pulmonary ACE2 during infection, which improved the pathologic conditions of ARDS directly. The gene discussed is ACE2; the disease is infection.